678 filings
Page 4 of 34
6-K
bv58jw6xs iax
30 Jun 22
Current report (foreign)
12:10pm
6-K
87ryipllghw404f
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
xrcr5t
16 Jun 22
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron
1:20pm
6-K
ta5m2v0j93n34s
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
v6h0 4a0ojjz6jtu4
7 Jun 22
Current report (foreign)
2:51pm
6-K
f41exos9h 2ch1mq8
31 May 22
Update on Cialis® Rx-to-OTC Switch Actual Use Trial
10:56am
6-K
3rrobtrj
25 May 22
FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
1:53pm
6-K
d39h9ij
17 May 22
Current report (foreign)
3:20pm
6-K
tjzl8y
16 May 22
IFRS net sales reported
1:45pm
6-K
leqdn y0hfow2sa
9 May 22
Approval of the financial statements for the fiscal year 2021
2:29pm
6-K
yjr z3ijl
29 Apr 22
Current report (foreign)
12:38pm
6-K
sgjq6r
28 Apr 22
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1
12:16pm
6-K
uhp979of
19 Apr 22
Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
11:32am
6-K
4du oe3rjiofnp0h
7 Apr 22
If approved, Dupixent would be the first medicine available in the U.S. indicated to treat eosinophilic esophagitis
3:13pm
6-K
l6c328h3ylnb8ovykgt
4 Apr 22
Distribution of Shares of Euroapi
11:21am
6-K
ohdixbn
1 Apr 22
French AMF approved EUROAPI’s listing prospectus
1:40pm
6-K
rzx0r39y1
31 Mar 22
Current report (foreign)
12:12pm
6-K
e11pv1v4ql
30 Mar 22
Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis
1:44pm
6-K
4f9u kzhhyej
22 Mar 22
Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates
2:29pm
6-K
t4d1scb89k0gp3q 5pce
15 Mar 22
Sanofi recognized by S&P as one of the most sustainability-committed companies
3:52pm